Gene delivery with bisphosphonate-stabilized calcium phosphate nanoparticles

Journal of Controlled Release

Volumn 150, Issue 1, 2011, Pages 87-93

  Giger, Elisabeth V ^a   Puigmartí Luis, Josep ^a   Schlatter, Rahel ^a   Castagner, Bastien ^a   Dittrich, Petra S ^a   Leroux, Jean Christophe ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Bisphosphonates; Calcium phosphate; Gene delivery; Nanoparticles

Indexed keywords

BIORESORBABLE; BISPHOSPHONATES; CALCIUM PHOSPHATE NANOPARTICLES; CO-PRECIPITATES; FUNCTIONALIZED; GENE DELIVERY; GENETIC MATERIALS; IN-VITRO; LOW TOXICITY; NUCLEIC ACID DRUGS; PHYSICAL STABILITY; RAPID DEGRADATION; SHORT PERIODS; SURFACTANT-FREE; SYNTHETIC METHODS; TRANSFECTION ACTIVITY;

BIOCHEMISTRY; CALCIUM; ETHYLENE; ETHYLENE GLYCOL; GENE THERAPY; GENE TRANSFER; NANOPARTICLES; NUCLEIC ACIDS; PHOSPHATES; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES; SURFACE ACTIVE AGENTS;

CALCIUM PHOSPHATE;

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM PHOSPHATE; DNA; MACROGOL; NANOPARTICLE; NUCLEIC ACID; SURFACTANT;

ADULT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PARTICLE SIZE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; ZETA POTENTIAL;

CALCIUM PHOSPHATES; DIPHOSPHONATES; DNA; HELA CELLS; HUMANS; NANOPARTICLES; POLYETHYLENE GLYCOLS; TRANSFECTION;

EID: 79951956792     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2010.11.012     Document Type: Article

References (45)

1. J. Alper, Drug delivery: breaching the membrane, Science 296 (2002) 838-839. (Pubitemid 34464874)
2. D. Luo, W.M. Saltzman, Synthetic DNA delivery systems, Nat. Biotechnol. 18 (2000) 33-37.
3. D.J. Glover, H.J. Lipps, D.A. Jans, Towards safe, non-viral therapeutic gene expression in humans, Nat. Rev. Genet. 6 (2005) 299-310.
4. P. Xu, G.K. Quick, Y. Yeo, Gene delivery through the use of a hyaluronate-associated intracellularly degradable crosslinked polyethyleneimine, Biomaterials 30 (2009) 5834-5843.
5. J.J. Green, B.Y. Zhou, M.M. Mitalipova, C. Beard, R. Langer, R. Jaenisch, D.G. Anderson, Nanoparticles for gene transfer to human embryonic stem cell colonies, Nano Lett. 8 (2008) 3126-3130.
6. X. Zhang, K.K. Sharma, M. Boeglin, J. Ogier, D. Mainard, J.-C. Voegel, Y. Mély, N. Benkirane-Jessel, Transfection ability and intracellular DNA pathway of nanostructured gene-delivery systems, Nano Lett. 8 (2008) 2432-2436.
7. M. Elsabahy, N. Wazen, N. Bayó-Puxan, G. Deleavey, M. Servant, M.J. Damha, J.-C. Leroux, Delivery of nucleic acids through the controlled disassembly of multifunctional nanocomplexes, Adv. Funct. Mater. 19 (2009) 3862-3867.
8. M.-A. Yessine, M.-H. Dufresne, C. Meier, H.-U. Petereit, J.-C. Leroux, Proton-actuated membrane-destabilizing polyion complex micelles, Bioconjug. Chem. 18 (2007) 1010-1014.
9. S.D. Li, L. Huang, Gene therapy progress and prospects: non-viral gene therapy by systemic delivery. Gene Ther. 13 (2006) 1313-1319. (Pubitemid 44323687)
10. S.D. Patil, D.G. Rhodes, D.J. Burgess, DNA-based therapeutics and DNA delivery systems: a comprehensive review, AAPS J. 7 (2005) E61-77.
11. M. Ogris, S. Brunner, S. Schüller, R. Kircheis, E. Wagner, PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery, Gene Ther. 6 (1999) 595-605.
12. F.L. Graham, A.J. Van der Erb, A new technique for the assay of infectivity of human adenovirus 5 DNA, Virology 52 (1973) 456-467.
13. M. Okazaki, Y. Yoshida, S. Yamaguchi, M. Kaneno, J.C. Elliott, Affinity binding phenomena of DNA onto apatite crystals, Biomaterials 22 (2001) 2459-2464. (Pubitemid 32706446)
14. M. Jordan, A. Schallhorn, F.M. Wurm, Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formation, Nucleic Acids Res. 24 (1996) 596-601. (Pubitemid 26085833)
15. J.V. O'Mahoney, T.E. Adams, Optimization of experimental variables influencing reporter gene expression in heptoma cells following calcium phosphate transfection, DNA Cell Biol. 13 (1994) 1227-1232.
16. A. Loyter, G. Scangos, D. Juricek, D. Keene, F.H. Ruddle, Mechanisms of DNA entry into mammalian cells: II. Phagocytosis of calcium phosphate DNA co-precipitate visualized by electron microscopy, Exp. Cell Res. 139 (1982) 223-234. (Pubitemid 12021924)
17. E. Orrantia, P.L. Chang, Intracellular distribution of DNA internalized through calcium phosphate precipitation, Exp. Cell Res. 190 (1990) 170-174.
18. V. Sokolova, A. Kovtun, R. Heumann, M. Epple, Tracking the pathway of calcium phosphate/DNA nanoparticles during cell transfection by incorporation of red-fluorescing tetramethylrhodamine isothiocyanate-bovine serum albumin into these nanoparticles, J. Biol. Inorg. Chem. 12 (2007) 174-179. (Pubitemid 46197942)
19. S. Zaitsev, I. Buchwalow, A. Haberland, S. Tkachuk, I. Zaitseva, H. Haller, M. Böttger, Histone H1-mediated transfection: role of calcium in the cellular uptake and intracellular fate of H1-DNA complexes, Acta Histochem. 104 (2002) 85-92. (Pubitemid 34289844)
20. J. Schwiertz, A. Wiehe, S. Gräfe, B. Gitter, M. Epple, Calcium phosphate nanoparticles as efficient carriers for photodynamic therapy against cells and bacteria, Biomaterials 30 (2009) 3324-3331.
21. E.İ. Altinoǧlu, T.J. Russin, J.M. Kaiser, B.M. Barth, P.C. Eklund, M. Kester, J.H. Adair, Near-infrared emitting fluorophore-doped calcium phosphate nanoparticles for in vivo imaging of human breast cancer, ACS Nano 2 (2008) 2075-2084.
22. M. Kester, Y. Heakal, T. Fox, A. Sharma, G.P. Robertson, T.T. Morgan, E.İ. Altinoǧlu, A. Tabaković, M.R. Parette, S.M. Rouse, V. Ruiz-Velasco, J.H. Adair, Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer cells, Nano Lett. 8 (2008) 4116-4121.
23. T.T. Morgan, H.S. Muddana, E.İ. Altinoǧlu, S.M. Rouse, A. Tabaković, T. Tabouillot, T. J. Russin, S.S. Shanmugavelandy, P.J. Butler, P.C. Eklund, J.K. Yun, M. Kester, J.H. Adair, Encapsulation of organic molecules in calcium phosphate nanocomposite particles for intracellular imaging and drug delivery, Nano Lett. 8 (2008) 4108-4115.
24. M. Epple, K. Ganesan, R. Heumann, J. Klesing, A. Kovtun, S. Neumann, V. Sokolova, Application of calcium phosphate nanoparticles in biomedicine. J. Mater. Chem. 20 (2010) 18-23.
25. Y. Kakizawa, S. Furukawa, K. Kataoka, Block copolymer-coated calcium phosphate nanoparticles sensing intracellular environment for oligodeoxynucleotide and siRNA delivery, J. Control. Release 97 (2004) 345-356. (Pubitemid 38759491)
26. Y. Kakizawa, S. Furukawa, A. Ishii, K. Kataoka, Organic-inorganic hybrid-nanocarrier of siRNA constructing through the self-assembly of calcium phosphate and PEG-based block aniomer, J. Control. Release 111 (2006) 368-370.
27. E.H. Chowdhury, M. Kunou, M. Nagaoka, A.K. Kundu, T. Hoshiba, T. Akaike, High-efficiency gene delivery for expression in mammalian cells by nanoprecipitates of Ca-Mg phosphate, Gene 341 (2004) 77-82. (Pubitemid 39335885)
28. V.V. Sokolova, I. Radtke, R. Heumann, M. Epple, Effective transfection of cells with multi-shell calcium phosphate-DNA nanoparticles, Biomaterials 27 (2006) 3147-3153. (Pubitemid 43247588)
29. Y. Kakizawa, K. Kataoka, Block copolymer self-assembly into monodispersive nanoparticles with hybrid core of antisense DNA and calcium phosphate, Langmuir 18 (2002) 4539-4543. (Pubitemid 35390132)
30. J. Li, Y.-C. Chen, Y.-C. Tseng, S. Mozumdar, L. Huang, Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery. J. Control. Release 142 (2010) 416-421.
31. M. Zhang, K. Kataoka, Nano-structured composites based on calcium phosphate for cellular delivery of therapeutic and diagnostic agents, Nano Today 4 (2009) 508-517.
32. S. Bisht, G. Bhakta, S. Mitra, A. Maitra, pDNA loaded calcium phosphate nanoparticles: highly efficient non-viral vector for gene delivery, Int. J. Pharm. 288 (2005) 157-168.
33. I. Roy, S. Mitra, A. Maitra, S. Mozumdar, Calcium phosphate nanoparticles as novel non-viral vectors for targeted gene delivery, Int. J. Pharm. 250 (2003) 25-33.
34. H. Fleisch, Bisphosphonates: mechanisms of action, Endocr. Rev. 19 (1998) 80-100.
35. R.G.G. Russell, M.J. Rogers, Bisphosphonates: from the laboratory to the clinic and back again, Bone 25 (1999) 97-106. (Pubitemid 29322070)
36. H. Fleisch, R.G.G. Russell, D.F. Marion, Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo, Science 165 (1969) 1262-1264.
37. N.M. Hansen, R. Felix, S. Bisaz, H. Fleisch, Aggregation of hydroxyapatite crystals, Biochim. Biophys. Acta 451 (1976) 549-559.
38. P.D. Papapetrou, Bisphosphonate-associated adverse events, Hormones 8 (2009) 96-110.
39. S.G. Carter, D.W. Karl, Inorganic phosphate assay with malachite green: an improvement and evaluation, J. Biochem. Biophys. Methods 7 (1982) 7-13.
40. R.E. Kingston, C.A. Chen, H. Okayama, in: J.S. Bonifacino, M. Dasso, J.B. Harford, J. Lippincott-Schwartz, K.M. Yamada (Eds.), Curr Protoc Cell Biol., vol. 20, 2003.
41. D. Olton, J. Li, M.E. Wilson, T. Rogers, J. Close, L. Huang, P.N. Kumta, C. Sfeir, Nanostructured calcium phosphates (NanoCaPs) for non-viral gene delivery: influence of the synthesis parameters on transfection efficiency, Biomaterials 28 (2007) 1267-1279. (Pubitemid 44809431)
42. R. Gref, Y. Minamitake, M.T. Peracchia, V. Trubetskoy, V. Torchilin, R. Langer, Biodegradable long-circulating polymeric nanospheres, Science 263 (1994) 1600-1603. (Pubitemid 24128361)
43. T. Yuda, K. Maruyama, M. Iwatsuru, Prolongation of liposome circulation time by various derivatives of polyethyleneglycols, Biol. Pharm. Bull. 19 (1996) 1347-1351. (Pubitemid 26363633)
44. T.M. Allen, Long-circulating (sterically stabilized) liposomes for targeted drug delivery, Trends Pharmacol. Sci. 15 (1994) 215-220.
45. M.C. Woodle, Sterically stabilized liposome therapeutics, Adv. Drug Deliv. Rev. 16 (1995) 249-265.